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Abstract 
Individuals at t he  same age  in t he  same population differ along numerous risk 
fac tors  tha t  affect  the i r  chances of various causes of death. The f ra i l  and suscep- 
tible tend to die f i rs t .  This differential selection may partially account for some of 
t he  puzzles in cance r  epidemiology, including the  lack of apparen t  progress  in 
reducing cancer  incidence and mortality rates over  time. 
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Cancer Rates over Age. Time and Place: 
Insights i t o m  Stochastic Models 
of Heterogeneous Populations 
James W. Vaupel*. Anatoli  I. Yashin** 
MTRODUCTION 
The epidemiology of cancer  seems peculiar, puzzling, even paradoxical: 
- cancer  incidence and mortality rates level off o r  even decline a t  older ages; 
- cancer  accounts f o r  a g rea t e r  proportion of deaths  around ages  50 o r  60 than 
a t  younger o r  older ages; 
- when the  age  t rajector ies  of cancer  rates f o r  two cohorts, from different time 
periods, countries, histological types, etc., are compared, a crossover  o r  at 
least some convergence with age is frequently evident, s o  tha t  the  cohort  tha t  
is disadvantaged at younger ages is less disadvantaged o r  even advantaged a t  
older ages; 
- incidence and mortality rates f r o m  various forms of cancer  differ f a r  more 
from country to country than do rates of total cancer  incidence and mortality; 
- countries with high age-specific cancer  rates tend t o  have low age-specific 
mortality r a t e s  from other  causes and countries with high age-specific mor- 
tality rates from other  causes tend to have low age-specific cancer  ra tes ;  
- despite evidence tha t  some people are highly susceptible to more than one 
form of canaer ,  people who have one cancer  do not have significantly in- 
creased chances of coming down with a second, different variety; 
- mortality from s o m e  forms of canaer ,  notably lung cancer ,  is increasing, 
whereas mortality from some o ther  forms of cancer, especially stomach canc- 
er and cancer  of the  uterus,  is decreasing; 
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- overall, cancer  incidence and mortality rates are tending to somewhat in- 
c rease ,  whereas mortality rates from almost all o t h e r  major causes of death,  
including hear t  disease and cerebrovascular  disease, are declining. 
The various f o r m s  of cancer  and o t h e r  causes of death can be  considered 
competing r isks .  in analyzing pat terns  of cause-specific mortality, two assump- 
tions are usually made: 
(1) individuals of t h e  same age  in t h e  same population group face  t h e  same proba- 
bility of death f r o m  each of t h e  various causes,  and 
(2) t he  competing r i sk s  are independent of each other :  a change in t h e  force of 
mortality (i.e., t h e  intensity or hazard of death by age) f r o m  any specific 
cause i s  assumed to have no impact on t h e  fo rce  of mortality from any o t h e r  
cause (Chiang 1968, Keyfitz 1985, but see Cohen and Liu 1986 and Yashin et al.  
1986). 
The f i r s t  assumption is clearly inconsistent with t h e  generally recognized fac t  
tha t  individuals, even of t he  same age  and in t h e  same population or subpopulation, 
differ in the i r  overall  frail ty and in the i r  susceptibility to various causes of death. 
Physicians, epidemiologists, biostatisticians, and demographers have long recog- 
nized tha t  individuals differ along numerous r isk factors ,  some observed and oth- 
ers unobserved, some genetic in origin and o the r s  resulting f r o m  behavior and en- 
vironmental exposure,  tha t  influence morbidity and mortality rates. 
We show tha t  this  heterogeneity implies tha t  t h e  second assumption i s  a lso in- 
valid: in a heterogeneous population competing r i sks  of death will not, except  in 
special circumstances, be  independent on t h e  population level, even though t h e  
competing r i sk s  may be  independent f o r  every  individual in t he  population. 
Even if an  assumption i s  invalid i t  might be  useful as a simplifying approxima- 
tion. The question thus is: are t he  effects of heterogeneity and t h e  resulting 
dependency among oompeting r i sks  small enough to be  ignored? The models w e  
develop suggest tha t  the  effects might be sufficiently substantial t o  at least par- 
tially account for t h e  puzzles and paradoxes in t h e  epidemiology of cancer  listed 
above. 
That selection in a heterogeneous population might be  at least a contributing 
cause of t h e  leveling off and decline with age  in cancer  rates i s  a hypothesis fami- 
l i a r  to cancer  epidemiologists, although i t  has  tended to b e  dismissed. Therefore,  
w e  start with this effect and devote a la rge  sha re  of t h e  a r t ic le  to scrutinizing it. 
Two major conclusions emerge: 
(1) a variety of alternative models of selection and competing r isks  can produce 
the  leveling off and decline, and even if most of these models are implausible, 
some variant o r  o the r  may prove appropriate ,  and 
(2) even if substantial heterogeneity exists in a population no noticeable leveling 
off o r  decline may be  apparent ,  so the  absence of this kind of effect is not 
evidence against heterogeneity. 
We then turn  to illustrating how heterogeneity may be at least a part ia l  cause 
of puzzles and paradoxes of cancer  epidemiology involving variation in cancer  
rates over  time and place, instead of over  age. Probably ou r  most significant find- 
ing, given t h e  scientific and policy interest in cancer  trends, is  tha t  observed 
cancer  rates in a heterogeneous population may increase over  time even though 
the  r isks  of cancer  f o r  individuals are declining. W e  explain t h r e e  different 
mechanisms tha t  can produce this effect. 
AGE PATTEBNS 
The Rise and Fall o f  Cancer Trajectories: Background 
Cancer incidence and mortality ra tes ,  for most forms of cancer  in m o s t  coun- 
t r ies ,  increase at a declining rate with age, showing some leveling off before some 
age  and, quite often, reaching a maximum and then declining (Engel and Larsson 
1967, Cook et al. 1969, Waterhouse et al. 1976, Muir 1978, Segi et a l .  1981, Young 
et al. 1981, Magnus 1982, Heston 1986). The most common pat tern shows cancer  
rates increasing at least up to age  75, with marked leveling off o r  decline occur- 
ring, if at all, at more advanced ages where data  may be unreliable. The second 
basic pa t te rn  shows a definite peak in cancer  rates. e i ther  at a fairly young age 
and o r  in middle age, with declining rates a f t e r  this peak. 
The first pat tern,  with cancer  rates increasing at a decreasing r a t e ,  can be 
modeled by a power (or  Weibull) function of t h e  form p (2 )  = b x k ,  where p ( z )  is the 
hazard rate of incidence o r  mortality at age  x and b and k are parameters (Nor- 
dling 1953, Armitage and Doll 1954). In many cases, however, the  incidence (or  
mortality) rates r i se  even less rapidly than a p o w e r  curve  and, as noted above, 
show a distinct leveling off and even decline at advanced ages. In a n  analysis of 
cancers  with rates t ha t  generally increase with age, Cook et al. (1969) examined 
338 data sets f o r  24 types of cancer  in males, females, o r  both in eleven countries 
f o r  ages 35 to 74: '?n 54% (181 out of 338), t h e  lines showed downward curvature,  
that  is, the rate of increase with age w a s  less than predicted by [a power func- 
tion]". Numerous o the r  data sets ,  both for periods and for cohorts. also show a 
distinct leveling off of many cancer  rates at older ages, especially at ages after 75 
(Waterhouse et al .  1976, Segi e t  al. 1981, Young e t  al. 1981, Magnus 1982, Heston 
1986). 
The second basic pat tern of cancer  incidence and mortality rates shows a de- 
finite peak at a n  age  a t  which data  are generally considered to be reliable. Many 
nonepithelial tumors (such as leukemias o r  sarcomas) f i t  this pattern; the  nonep- 
ithelial tumors, which account f o r  only roughly 10 percent  of fatal  malignant tu- 
mors, may be produced by different mechanisms than epithelial tumors (Peto 1977). 
There a r e ,  however, also examples of carcinomas (i.e., epithelial tumors) that  fol- 
low this second pattern. For instance, over  t he  period 1973-77, t he  incidence of 
lung cancer  peaked at about age 65  fo r  U.S. females and the  incidence of testicular 
cancer  peaked a t  about age 25 f o r  U.S. males (Young et al. 1981). The incidence of 
cervical cancer  among various cohorts of Danish, Finish, Icelandic, Norwegian, 
and Swedish women shows peaks at ages, depending on the  cohort and the  country, 
ranging from about 40 to about 60 (Hakama 1982). In the  case of t h e  lung cancer ,  
the  pat tern of sha rp  decline in period cancer  rates (i-e., rates pertaining t o  some 
particular period of time, such as 1973-1977) can be largely explained by differ- 
ences among cohorts,  probably due to differences in smoking behavior (Doll 1980). 
Nonetheless, cohort pat terns  of lung cancer  incidence and mortality also exhibit a 
definite leveling off and even some decline (Manton and Stallard 1981a and 1982, 
Day and Charnay 1982, Kvaale 1982, Sandstad 1982, Tuyns 1982, Manton e t  al. 
1986). 
The leveling and falling off of cancer  rates is  puzzling because the  force  of 
mortality f o r  m o s t  causes of death and f o r  all  causes of death combined is most 
commonly modeled by an  exponential (Gompertz) curve, at least until very ad- 
vanced ages,  and because theories  of the  causes of aancer  suggest tha t  the  in- 
cidence of cancer  should increase with age (Hiatt et al. 1977, Cairns 1978). The 
observation tha t  t he  age-trajectory of many aancer  rates resembles a power func- 
tion, at least before age 70 o r  so, led epidemiologists t o  develop various theories,  
most involving some multistage process,  tha t  imply a power function (or  some simi- 
larly shaped t rajectory)  f o r  cancer  rates (Armitage and Doll 1954 and 1961, Burch 
1965, Peto 1977, Watson 1977, Moolgavkar 1986). Which of these theories,  if any, 
appropriately captures  the  etiology of cancer  is, however, as yet unknown, given 
available ancillary theory and evidence, but it does seem likely tha t  some kind of 
multistage process underlies the generation of m o s t  human cancers  (Peto 1977). 
Numerous explanations have been suggested to explain the  downward devia- 
tion of many cancer  t ra jec tor ies  f r o m  the  hypothesized power function pat tern,  in- 
cluding genetic heterogeneity among individuals in t he i r  susceptibility, environ- 
mentally acquired heterogeneity, age-related changes in insult, distortions in 
period data  resulting from differences among cohorts,  undercertification among 
the  old, the  effects of the time i t  takes a tumor to grow, and the  effects  of aellular 
event rates tha t  are not small (Peto 1977, Muir 1978). Explanations based on the  
elimination of genetically-susceptible population groups have tended to be 
dismissed (Cook et al. 1969, Miller 1980). in p a r t  because of the  s t rong evidence, 
from migrant studies (Haenszel 1982) and studies of t he  causes of lung cancer  and 
o ther  cancers (Doll and Peto 1981). tha t  behavioral and environmental factors  
must be very important. 
Nonetheless, t h e r e  appear  to be  substantial genetic differences among indivi- 
duals, especially regarding genetic predisposition to environmental carcinogens 
(Knudson 1977, Cairns et al. 1980, Calabrese 1984, Mueller and Weber 1985, Teppo 
1985, Ooi 1986), and the  existence of strong genetic differences is not inconsistent 
with observed epidemiological pat terns  (Peto 1980) o r  with the  c lear  importance of 
environmental fac tors  (Knudson 1977). Moreover, even if susceptibility t o  some 
form of cancer  is not influenced by genetic faators ,  susceptibility is influenced by 
various behavioral and environmental factors-e.g., c igaret te  smoking, consump- 
tion of green vegetables, o r  exposure to asbestos-that differ among the  members 
of a population, leading to t he  formation, a f t e r  birth, of more or less susceptible 
groups (F'raumeni 1975, S tern  1977, Calabrese 1978 and 1980). Indeed, multistage 
theories of cancer  imply heterogeneity, because different individuals, even of t he  
same age, will be  at different stages. 
Several alternative models tha t  recognize heterogeneity among individuals in 
frail ty and susceptibility yield population t rajector ies  of cancer rates tha t  r ise ,  
level off, and perhaps decline even though cancer  t ra jector ies  fo r  the individuals 
tha t  comprise the  population rise steadily (Cook et al. 1969, Peto 1980, Manton and 
Stallard 1980 and 1982, Manton et al. 1979 and 1986; fo r  more general reviews, see 
Economos 1982, Keyfitz 1985 and Vaupel and Yashin 1985a and b). 
Using cohort  data  on mortality from lung cancer  among U.S. whites, Manton et 
al. (1986) investigated twelve different models based on alternative assumptions 
about the age-specific pat tern of mortality r isks  fo r  individuals and about the  dis- 
tribution (if any) of mortality r i sks  across  individuals. For U.S. females, t he  best 
fitting model used an  exponential function f o r  the  age  trajectory of lung cancer  
mortality, although f o r  U.S. males, the  best fitting model used a power function. 
Employing the s a m e  approach t o  analyze total  mortality from all causes f o r  various 
U.S. cohorts,  Manton et al. found the  best fitting power function and exponential 
function models f i t  t he  data  virtually equally wel l ,  f o r  both female and male data. A 
lesson h e r e  is tha t  i t  may be difficult to discriminate, using epidemiological data,  
between models based on different mortality functions, even though the  different 
functions may have radically different theoretical implications about t he  etiology 
of cancer;  Pe to  (1980) discusses this. It should be noted that in Manton et al.'s 
analyses, m o d e l s  tha t  assumed a considerable degree of population heterogeneity 
fi t  the data much be t te r  than models assuming homogeneity among individuals in 
mortality risks.  
The Rime a n d  Fal l  o f  C a n c e r  Trajectories:  Some Simple Models 
One model of cancer  mortality (or  incidence) in a heterogeneous cohort is il- 
lustrated in Figure la; w e  w i l l  call this  t he  prototypical susceptibility model. Some 
individuals a r e  susceptible t o  some part icular  form of cancer  (or,  alternatively, t o  
cancer  in general); o thers  are immune. This differential susceptibility could be 
the  resul t  of genetic, behavioral, o r  environmental factors.  A t  star t ing age  zero, 
which may be some age substantially later than birth t o  allow environmental risk 
factors  t o  create the  two sub-cohorts, a proportion no a r e  susceptible. For these 
individuals, the  force  of mortality from the cancer  at age  z is pC (2) ;  f o r  both sus- 
ceptible and immune individuals the  force  of mortality from o the r  causes of death 
is &(z). The observed force  of mortality from the  cancer  f o r  the population as a 
whole, Ec (z ) ,  is given by: 
where n ( z )  denotes t he  proportion of the population alive at age z tha t  is susoep- 
tible t o  the  cancer .  This proportion is given by: 
o r ,  cancelling and rearranging, by: 
The formula developed by Pe to  and presented in Cook et al. (1969) as formula 
( v )  is, with appropriate  change in notation and some rearrangement,  equivalent t o  
formula (3). Note that  t h e  force of mortality f r o m  oauses o the r  than the  cancer  
does not appear in this  formula and hence does not influence the  cancer  tmjecto- 
ry .  Thus in this simple model, the  cancer  and the  o ther  causes of death are in- 
dependent r isks  on both the  individual and population levels. 
Figure 2a displays population t rajector ies  of the oancer  mortality r a t e s ,  &, 
produced by curves for the  cancer  mortality rates among susceptible individuals, 
&, given by a power function. The five curves in t he  figure, which differ because 
different pammeter  values were used in the underlying model, a r e  reminisoent of 
observed tmjectories of cancer  mortality, as displayed, f o r  instance, in Segi et al. 
(1981) or Magnus (1982). Two parameters were used in drawing the  curves- 
no = n(O), the  proportion susceptible, and a parameter,  called C, t ha t  gives the  
cumulative proportion of t he  susceptible population tha t  would suffer this  cancer  
by age 75 if they did not die of something else before then. This parameter C can 
be interpreted as a measure of how much selection has taken plaoe among the  sus- 
ceptible population by age  75. For each of the  curves,  t h e  power k in t he  power 
function p ( z )  w a s  taken to be 6, a frequently used value in cancer  studies. Given 
C and k ,  t he  scaling factor b in the  power function can be easily calculated. The 
proportion of the en t i re  population tha t  would suffer t h e  cancer  by age  75 is given 
by no t i m e s  C; fo r  each of t he  five curves in the Figure Za this  product w a s  held 
constant at 1 peroent. Hence the  curves can be interpreted as being detiermined 
by the  five values ohosen for C, namely 1 percent,  10 percent,  50 percent ,  80 per- 
cent,  and 100 percent .  The curves thus illustrate how the  impact of selection on a 
cancer  trajectory depends on the  degree of selection tha t  has occurred. Experi- 
ments with o ther  values of the  product of C and no indicate tha t  variation in how 
common the cancer  is among the en t i re  population has hardly any effect on the 
shape of the  trajectories compared with the  effect of changes in C (at  any con- 
s tant  level of C times no). 
Cook et at .  (1969) present,  in their  Figure 4, some curves similar t o  the  ones 
in Figure 2a. They reject the importanoe of differential susceptibility, but the i r  
logic pertains t o  innate susceptibility m t h e r  than susceptibility acquired by 
behavior or environmental exposure and the i r  evidence is based on some uncompli- 
cated analysis of limited data  pertaining t o  period rates f o r  seven cancers  in 
eleven aountries, with a cutoff age of 74. 
The prototypiaal susceptibility model in Figure l a  might be  generalized t o  the  
prototypical frail ty model shown in Figure l b .  Here the  force  of mortality from 
causes o the r  than the  cancer  differs in t he  two subpopuletions. If % is  g rea t e r  
than &, then the  individuals in the  f i r s t  subpopulation might be called frail ,  be- 
cause they are susceptible to the  cancer  and have a higher chance of death from 
o the r  causes as well. This may be reasonable if risk factors  associated with the  
cancer ,  whether genetic, behavioral o r  environmental, tend also t o  be associated 
with o the r  causes of death o r  if persons with the cancer  are weakened such tha t  
they have a higher chance of dying from other  causes. For this frail ty model, the  
death rate from the  cancer  in t he  population, zc, is  given. as before,  by (I) ,  but n 
now depends on both pC and b: 
The death rate from other  causes in t he  population, &, i s  given by 
so  now & and &, are linked (via t he i r  common dependence on n): on the  population 
level, the  cancer  and the  o ther  causes are not independent r i sks  even though they 
are independent f o r  every individual in the  population. For instance, if & de- 
creases ,  then & wi l l  also decrease but & will increase. 
This prototypical frail ty model aan produce, depending on the  parameters 
used, populations t rajector ies  of cancer  mortality tha t  rise and fall o r  tha t  r i s e  
and then level off before the  cutoff age. 
Some fu r the r  directions f o r  generalization of t he  susceptibility and fraility 
models are suggested in Figure lc. Instead of being susceptible o r  immune, indivi- 
duals might b e  more or less susceptible to the  cancer  under study. The parame- 
ters X and A' represent  intensities of flow from one state t o  the  other .  Individuals 
might become more susaeptlble to the  cancer  as a resul t  of, e.g., c igaret te  smoking 
o r  exposure to  radiation. On the o ther  hand, individuals, by giving up cigaret te  
smoking or changing jobs, might reduce the i r  susceptibility. The forae  of mortali- 
ty from o the r  causes, &, and &, might also differ in t he  two states.  If individuals 
who a r e  susceptible to the  cancer  a r e  frai l  o r  debilitated, &, might be g rea t e r  
than &. If, on the  o the r  hand, the  risk factors  tha t  increase the  chances of the 
cancer  decrease the chanaes of, say, hear t  disease, then & might be g rea t e r  than 
&,. In any case,  in this model the  two causes of death a r e  not independent on the 
population level: a change in the observed force  of mortality from the  cancer  will 
produce a change in the observed force of mortality from o the r  causes and visa 
versa.  
The model can be explored by running the following formulas and differenae 
equations on a personal computer: 
Remarkably, a wide variety of different t ra jector ies  f o r  the p's and A ' s  yield the  
same qualitative results: observed, population mortality t ra jector ies  for the  canc- 
er r ise ,  level off, and then, depending on the parameter values and the  cutoff age, 
may decline. The driving feature of the model is tha t  some individuals are more 
susceptible to the  cancer  than o the r  individuals. The more susceptible individuals 
tend to die f i rs t .  A s  they die, the  proportion of the surviving population at 
grea t e r  r isk falls, and mortality rates from the  cancer  appear ,  on the population 
level, to level off or even decline. 
A s  a n  illustration of this general point, consider the model shown in Figure Id.  
In this model, individuals a r e  assumed, at starting age  zero,  to be  immune from 
some cancer:  people gradually become susceptible to the cancer  at a constant 
r a t e  A. Susceptible individuals a r e  assumed not only t o  be susaeptible t o  the canc- 
er being studied, but also to a related set of cancers.  In terms of a multistage 
model, the transition from immune to susceptible can be considered a transition 
common to a group of cancers ,  a transition based on some environmental o r  
behavioral fac tor  tha t  is a r isk fac tor  f o r  all the various cancers  in the group. 
This model, which we call the two-cancer transition model, was used t o  produce the 
curves shown in Figure 2b: the  more important o the r  cancers  are as a cause of 
death, t he  more bowed is the  t rajectory f o r  the  cancer  being studied. 
In addition t o  demonstrating tha t  t h e r e  a r e  a variety of ways in which selec- 
tion in a heterogeneous population can cause the age  t rajectory of cancer  r a t e s  to 
level off o r  even decline, t he  various models presented above can be used to show 
tha t  even substantial heterogeneity may produce only weak effects on age  trajec- 
tories. Using the  variant diagrammed in Figure l e ,  Pe to  (1980) demonstrates tha t  
even in cases where predisposed individuals-be they 1 percent,  1 0  percent  o r  50 
percent  of the  total  population-suffer 50 times the  incidence of some cancer  com- 
pared with the rest of the population, the  age ' trajectory of cancer  incidence in 
the population as a whole may closely mimic, at least up to age 75 or so, the  age 
t rajectory of a homogeneous population. Other variants of the  model diagrammed 
in Figure l c  can produce similar results;  some of the t rajector ies  in Figures 2a and 
b a r e  examples. Thus, although heterogeneity may be  a possible explanation f o r  
some of t he  observed leveling off and decline in cancer  t ra jector ies ,  the absence 
of apparent  leveling off or decline does not imply homogeneity or even approxi- 
mate homogeneity. This is reassuring because i t  is virtually cer tain tha t  substan- 
tial heterogeneity exists, produced by various genetic, behavioral, and environ- 
mental r isk factors ,  f o r  cancers  of all types. A key question tha t  thus ar ises-and 
which will be addressed in subsequent sections-is the possible impact heterogenei- 
ty might have on time t rends  and geographic variations. even in those cases where 
the heterogeneity does not have a substantial effect on age  trajectories.  
More elaborate models. with many states of susceptibility or a continuous dis- 
tribution of susceptibility and with susceptibility changing with age or time, aan be 
developed (Beard 1963, Vaupel e t  al. 1979 and 1986, Manton and Stallard 1984, 
Yashin et al. 1985). In empirical analyses of par t icular  forms of cancer  o r  o ther  
causes of death, i t  may be appropriate  to use models complicated enough t o  cap- 
t u re  the key details of the  disease process. Here o u r  purpose is not statistical 
inference but insight. We will henceforth illustrate ou r  examples with a single 
model that  aap tures  the key fea ture  driving the process; i t  turns out that in all  in- 
stances it i s  sufficient to use models as simple as t he  prototypical susceptibility 
model in Figure l a ,  f o r  which the r isk of the  cancer  is independent of o ther  mor- 
tality r isks ,  or the  prototypical frail ty model in Figure I b ,  f o r  which the  mortality 
r isks  a r e  linked on the  population level although they are independent f o r  all  indl- 
viduals. 
Successive Apogees  
Figure 3a displays the  age  t rajector ies  of incidence rates from cervical canc- 
er for  t h ree  birth cohorts  of Icelandic women (redrawn from data  in Hakama 1982). 
Similar pat terns  of crossover and successive apogees can be found f o r  o the r  
cohorts,  o the r  countries, and o ther  forms of cancer ,  e.g., f o r  cervical cancer  in 
Denmark (Hakama 1982), cancer  of the larynx f o r  French males (Tuyns 1982). 
cancer  of the  bone among Japanese m a l e s  and females (Saki et al. 1981), and 
leukemia among survivors of the  atomic bomb at tacks in Japan and lung cancer  
among insulation workmen (Nicholson 1985). 
The prototypical susceptibility model, shown in Figure l a  and described by 
formulas (1) and (3). yields sucoessive apogees tha t  resemble observed patterns.  
One simulation i s  presented in Figure 3b; in this simulation, the  t rajector ies  shift  
to the  r ight  as t he  mortality rate declines and the t rajector ies  reach higher peaks 
as the proportion of the population susceptible to the  cancer  increases. A s  indi- 
cated above, a variety of o the r  heterogeneity models, including models  in which 
the  observed rates of cervical cancer  are increasing because competing causes of 
death are decreasing, oan be used to produce t rajector ies  similar to those in Fig- 
u re s  3a. W e  present  Figure 3b, and the  simple model underlying it ,  not as a n  expla- 
nation of cervical cancer  trends in Iceland but as an  illustration of the  fac t  tha t  
such t rends are consistent with the  operation of selection in heterogeneous popu- 
lations and hence might be partially accounted f o r  by an  appropriate  heterogenei- 
ty model. 
Although clear examples of successive mortality apogees f o r  successive 
cohorts are unusual, perhaps because the  age t ra jector ies  are usually cutoff at 
some age  like 75 or 80 before the  full effects of selection can be seen, examples of 
crossover or strong convergence are more common, as illustrated by the  various 
cohort graphs in Segi et al. (1981) and Magnus (1982). An interesting instance of 
a crossover in incidence rates is  given Hanai et al. (1982) f o r  stomach cancer  
among males and females in Osaka, Japan, who were classified into histologic 
groups. In addition, pat terns  of decline ove r  time in age-specific rates at younger 
ages and increases at older ages are evident f o r  all cancers  combined and f o r  
various specific cancers  in Japan (Segi et al. 1981) and o the r  countries: Figure 4, 
which displays the relative death rates in 1980 compared with 1970 from cancer  
and from o the r  causes among U.S. women from age 20 to 85, shows a crossover fo r  
oancer at age 55. 
Differential selection in a heterogeneous population, which has been widely 
accepted as at least a part ia l  explanation f o r  mortality crossover and conver- 
gence in several  areas (Manton and Stallard 1981b, Vaupel and Yashin 1985b), may 
provide at least a part ia l  explanation of these observations as well .  In any case, 
under fairly general conditions (Vaupel and Yashin 1985a), a decrease  in mortality 
rates at younger ages  will result ,  in a heterogeneous population, in an  increase at 
older ages and a uniform decrease in t h e  rates at all  ages will resul t  in an  ob- 
served mortality t ra jectory tha t  converges toward and may cross t h e  previous tra- 
jectory. I t  follows, however, from Peto's (1980) analysis, discussed above, tha t  
even strong heterogeneity and substantial cohort differences may not lead t o  no- 
ticeable convergence. Consequently, absence of convergence cannot be taken as 
evidence tha t  t h e  population is  homogeneous. 
The Falling Cancer Share 
Death rates from cancer  among U.S. women in 1980 rose more slowly with age  
than death rates from o the r  causes. A s  a result ,  oancer  accounted fo r  a declining 
sha re  of deaths with age: t he  sha re  of deaths accounted f o r  by canoer  fell from 43 
percent  at ages 50-54 to only 9 percent  at ages above 85. In contrast,  cardiovas- 
cular  diseases accounted f o r  28 percent  of deaths  at ages  50-54 and fully 71 per- 
cent at ages above 85. The declining canaer  s h a r e  and rising cardiovascular 
share ,  which can also be  observed f o r  males, o the r  times, and o ther  countries 
(Preston et al. 1972) is a n  implication of t h e  fact tha t  cancer  rates tend to r i s e  
even more slowly than a power function, whereas cardiovascular disease death 
rates (and total  death ra tes )  r i s e  exponentially. An interesting (and speculative) 
perspective on this can be  developed by using a simple model, like t h e  one in Fig- 
u r e  l a ,  tha t  recognizes tha t  people differ in the i r  susceptibility to canoer.  I t  may 
be that  among people who are susceptible t o  cancer,  t he  force  of mortality from 
canaer  i s  higher at al l  ages than the  foroe of mortality from, say, aardiovasoular 
disease. Indeed, t he  force  of mortality from cancer  among the  susceptible popula- 
tion may be increasing exponentially. Nonetheless t h e  observed age  t rajectory of 
cancer  mortality may cross  over  t h e  cardiovascular disease t rajectory.  
In t he  prototypical susceptibility model, t he  population fo rce  of mortality 
from cancer  is  given by formulas (1) and (3). Substituting (1) into (3) yields a n  in- 
tegral  equation fo r  n ( ~  ): 
Given the  t rajectory of z ( z )  and the  value of n(O), numerical methods can be  ap- 
plied to this equation to estimate the t raJectory of n(z) .  Then, by using (I) ,  the 
t rajectory of &(z) can be calculated. Thus, if the proportion of the  population at 
age zero that  is susceptible t o  cancer  is specified, i t  is possible t o  estimate the 
force  of mortality from cancer  among the susceptible population. In the model the  
force  of mortality from cardiovascular diseases is the  s a m e  f o r  all  individuals, re- 
gardless of the i r  susoeptibility to cancer,  so the individual and population death 
rates from cardiovascular disease are identical. 
Figure 5 w a s  constructed by taking the observed cardiovascular disease and 
oancer mortality t rajectories  as given in the 1980 U.S. mortality statistics f o r  fe- 
males; i t  w a s  assumed tha t  25 percent of t he  synthetic cohort experiencing these 
rates were susceptible to cancer  at the starting age of 20. The observed age- 
specific death rate from cancer  falls below the  death rate from cardiovascular 
disease a f t e r  age  60. The model, however, indicates tha t  t he  death rate from canc- 
er among susceptible individuals exceeds the  death rate from cardiovascular 
diseases at all  ages on the  graph. W e  emphasize tha t  this result  is presented as an 
illustration only; t he  model i s  simplistic and the  data faulty: selection operates  on 
rea l  cohorts, not synthetic ones. The point, however, remains: t he  age  t rajectory 
of cancer  mortality f o r  susceptible individuals might r i s e  considerable more quick- 
ly, reach considerably higher levels, and have a different shape than the  observed 
population t rajectory . 
VAlUATION WEE TIME AND PLACE 
Compensat ing Cancers 
The incidence of different kinds of cancer  varies  enormously, sometimes by 
several o rde r s  of magnitude, among various countries and regions (Doll and Peto 
1981, Muir and Nectoux 1982). For all forms of cancer  combined, t h e  variation 
tends to be less. Table 1 presents the  age-adjusted death rates f o r  various forms 
of cancer  and f o r  cancer  at all  sites f o r  the  country tha t  ranked 1st and the  coun- 
try that  ranked 40th in a data set fo r  1978-9 compiled by the  World Health Organi- 
zation (and presented in American Cancer Society 1985). (We chose rank 40 to 
avoid erroneous values associated with poor data collection and processing in 
some countries with very low reported rates;  t he  data f o r  the 1st ranked countries 
appeared fairly reliable, given i ts  consistency with values reported f o r  countries 
ranked 2 and 3). With the  exception of leukemia, the  ra t io  of t he  rates f o r  the 
various cancers ranges from about 4 t o  about 9, in contrast with a rat io of 2 for all 
cancers combined. Apparently when some f o r m s  of cancer are unimportant, other 
forms grow in importance to compensate for the deficit. 
Table 1. Age-adjusted death rates per  100,000 for various forms of cancer and 
for cancer a t  all sites fo r  the 1st and 40th mnked country. 
For For 
1st mnked 40th ranked 
Cancer Sex country country Ratio 
Om1 M 20.3 2.2 9.2 
F 7.2 0.8 9.0 
Prostate M 41.0 5.4 7.6 
Lung M 113.2 15.6 7.3 
F 30.9 5.0 6.2 
Colon and Rectum M 34.0 5.7 6.0 
Stomach M 66.1 14.4 4.6 
F 33.5 7.2 4.6 
Breast F 33.8 7.9 4.3 
Uterus F 30.0 7.5 4.0 
Colon and Rectum F 29.5 7.7 3.9 
Leukemia M 9.6 3.9 2.5 
F 6.3 2.8 2.3 
All sites M 275.0 135.0 2.0 
F 172.3 86.9 2.0 
Source American Cancer Society (1985). 
A similar phenomenon can be observed over time: in various countries a s  
some forms of cancer have declined in importance, others  have increased, so  that 
total cancer rates tend t o  be more steady than rates from particular forms of 
cancer. In the United States, for instance, age-adjusted lung cancer mortality 
rates have increased substantially over recent  decades, rates for stomach cancer 
and cancer of the  uterus have substantially declined, and various other cancer 
rates have shown considerable fluctuation, but the overall oancer mortality rate 
has remained relatively steady, showing only a small rate of increase (Newell in 
DeVita 1985, American Cancer Society 1985). 
Such compensating changes are consistent with a model that  assumes people 
differ In their susceptibility t o  canoer (or  some set of aancers). A simple version 
of such a model, which w e  call the multiple susceptibility model, is shown in Figure 
I f .  The population death rates f r o m  the two forms of cancer, z:(z ) and k2(z  ), are 
given by 
where, following (3). it can be shown that 
Hence, t he  two trajector ies  f o r  $(z) are linked. If I(:(z), say, declines, then n (z )  
will grow and E: will increase. Indeed, even if both 4 and L(,2 are declining, if 
more progress  is being made against cancer  1 than cancer  2, i t  may look, at ages 
old enough tha t  selection has had a major impact, as if cancer  2 is increasing. 
Table 2 summarizes t he  results of a simulation using this model. A t  all  ages, 
progress  is being made in reducing mortality from cancer 2 at a rate of 0.1 per- 
cent  p e r  year .  However, t he  observed rate of progress  in reducing cancer  2 is  
much less than this  and is negative at age  60 and subsequently. Note t he  magnitude 
of the  observed negative rate of progress  at ages 70 and 80 is 2.2 and 6.5 times the  
magnitude of the  actual rate f o r  susceptible individuals at these ages. The ob- 
served rate of progress  in reducing mortality from cancer  1 is also less khan the  
actual rate. This is another  manifestation of the  convergence and crossover of 
mortality t ra jector ies  discussed above: saving susceptible individuals at younger 
ages reduces observed rates of progress  in reducing mortality at older ages. For 
both forms of cancer  combined, the  overall r a t e  of progress  among susceptible in- 
dividuals is 0.57 percent  p e r  year  at all ages, but t he  observed overall  rate of 
progress  is considerably less a t  ages 60 and 70 and at age  80  i t  appears  as i t  the  
overall cancer  death rate is  increasing. 
Multiple Cancera 
The hypothesis tha t  some individuals may be  more susceptible than o ther  indi- 
viduals t o  several  different forms of cancer  (or  to cancer  in general) seems to run 
counter t o  the  widely accepted view that ,  as Cairns (1978) puts i t ,  "each of the  ma- 
jor cancers  behaves almost as an  independent entity; with few exceptions, people 
who have been successfully t rea ted  f o r  one cancer  are then nei ther  more nor  less 
likely in subsequent years  t o  come down with a second, different variety." Schoen- 
berg (1977) reviews the  evidence on multiple cancers  and presents  a detailed 
Table 2. Annual r a t e s  of progress  in reducing death rates a t  various ages f o r  
cancer  1, cancer  2, and cancer  1 and 2 combined, f o r  the  susceptible 
subpopulation and the  en t i re  population. 
Annual rate of progress in reducing death rate: 
from cancer 1 from cancer 2 from cancers 1 and 2 
Actual Observed Actual Observed Actual Observed 
rate for rate for rate for rate for rate for rate for 
euaceptible entire euaceptible entire susceptible entire 
Age population population population population population population 
Source Computer calculations using multiple susoeptibility model, desoribed in text, 
75 
with ~ ( 0 )  = 0.05 and d ( z )  = biz5, with bi chosen such that j d ( z  )& = 0.5 and 
0 75 
)& = 0.333. 
0 
analysis of t he  Connecticut Tumor Registry. He concludes: "Results f o r  non- 
simultaneously diagnosed malignant tumors from Connecticut indicate tha t  individu- 
als with one malignant neoplasm have 1.29 times the  r isk of developing a new in- 
dependent primary tumor compared t o  individuals who never had cancer  
(P < 0.01). However, the  increased risk of multiple primary tumors i s  highly 
selective on a site-specific basis". For example, women with breas t  cancer  had 1.9 
times the  r isk of cancer  of t h e  corpus uter i  and 0.5 times the risk of cancer  of t he  
pancreas; men with lung cancer  had 6.5 times the  r isk of cancer  of t he  kidney and 
men with cancer  of the  colon had 0.5 times the  r isk of lung cancer.  
To understand the  relationship of statistics such as these t o  t h e  heterogeneity 
models discussed in this paper ,  consider the  model shown in Figure Ig.  There a r e  
two kinds of cancer  in t he  model and two kinds of individuals. One cohort  of indivi- 
duals is more susoeptible to both kinds of cancer  than the o ther  cohort.  For sim- 
plicity i t  is assumed tha t  the  two cancers  have identical, independent incidence 
rates f o r  each of the two groups. Death i s  ignored in the  model because the con- 
c e r n  is with multiple cancers  among those who survive t o  some specified age. 
Let r denote the  relative r isk of incidence of e i ther  cancer  f o r  the  more sus- 
ceptible compared with the  less susceptible group; w e  will aall r t he  relative risk 
of cancer  incidence. Let R denote the  relative risk of cancer  2 among those who 
have developed cancer  1 compared with those who have not developed cancer  1; we 
will cdl R, which i s  essentially equivalent to the  statistic used by Schoenberg, the  
relative r isk of cancer  2 prevalence. The question is: what is the  relationship of R 
to r ? The answer, surprisingly, is tha t  the  value of R tells us very little about the  
value of r ;  and tha t  R can be fairly low (e.g., 1.29) when r is  extremely large o r  
even infinite. 
Let no (z ) ,  n l ( z ) ,  n 2 ( z  ), and nI2(z)  denote the number of individuals in the  
less susceptible cohort  at age  z who have no cancer. the  f i r s t  o r  the  second canc- 
e r ,  or both, respectively, and use the  same notation with a prime to denote t he  
numbers f o r  t he  more susceptible cohort. I t  is  not difficult to show tha t  f o r  both 
groups: 
and 
The value of n 0 ( z )  depends on the  function chosen f o r  the  transition rate A. If X 
is  assumed to be a power function 
then 
and 
The value of R ( z ) ,  which i s  t he  r a t i o  of the  probability of cancer  2 given cancer  1 
t o  the  probability of cancer  2 given the  absence of cancer  1, can then be calculat- 
ed by: 
Table 3 presents  t h e  value of R f o r  various values of t he  relat ive r isk of 
cancer  incidence, r, suffered by persons in t he  more susceptible group. As t he  
table suggests, t h e  value of R is  essentially independent of the  value of r when r is 
100 or more. When such a l a rge  differential exists between t h e  more and less sus- 
ceptible groups, R is approximately equal t o  the  inverse of t he  proportion of the  
population at age  ze ro  t ha t  is  susceptible. Thus a value of R of about 2 is  con- 
sistent with a model in which about half t h e  population i s  highly susceptible to both 
cancers.  Even when r is considerably less than 100, t he  value of r tends to be  
much l a rge r  than the  value of R.  For instance, a value of R of 1.25 is consistent 
with a model in which half t he  population is  t h r e e  times more susceptible to both 
kinds of cancer  than the  o t h e r  half of t he  population; if R i s  2, then the  m o r e  sus- 
ceptible group could b e  a th i rd  of the  total population with a re la t ive r isk of 10 or 
half of the  total population with a relative r isk of 100 or more. 
Table 3. The value of R, t h e  re lat ive r isk of cancer  2 prevalence, at age  65, f o r  
various values of r, t h e  relative r isk of cancer  incidence, and no, t he  
proportion who are highly susceptible. 
30- Calculations based on model described in text with k = 6 and b ohosen such 
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value of b a hundred times lower or twioe as high hardly alters the results. 
A simple example helps provide an  explanation of t he  difference between the  
relative r isk of cancer  incidence, r, and the  relative risk of cancer  2 prevalence, 
R. Suppose half t h e  population is  highly susceptible to cancer  1 and 2 and the  oth- 
er half is  essentially immune. More specifically, assume tha t  t he  more susceptible 
group faces  a risk of 2 percent  of developing e i ther  cancer  by age  65  whereas the  
risk fo r  t h e  less susceptible group is  a thousand times less. If someone gets canc- 
er 1 before age  65, t ha t  person is almost certainly a member of the  highly- 
susceptible group and thus has  a t w o  percent  chance of developing cancer  2 by age 
65. Because t he  chance of e i t he r  canaer  is  low, t h e  fac t  t ha t  someone does not 
have cancer  1 tells us  very  little about which group t h e  person is  in. Hence, since 
people without oancer  1 have about a fifty percent  chance of being susceptible, 
t he i r  chance of having cancer 2 by age  65 is  half of 2 percent.  Thus, having canc- 
er 1 only doubles t h e  chance of cancer  2, even though having cancer  1 is  very 
strong evidence t ha t  a person i s  highly susceptible-and highly susceptible people 
face  1000 times t h e  r isk of cancer  1 or 2. 
For some pa i r s  of cancers.  people having one cancer  seem to be  less likely to 
have t h e  second cancer  than people without t he  f i r s t  oancer  (Schoenberg 1977). 
This could imply t ha t  people highly susceptible to t h e  f i r s t  cancer  have low suscep- 
tibility to t he  second cancer .  Alternatively, however, i t  may be  t ha t  people in one 
group are more susceptible to both kinds of cancer ,  given tha t  they have neither 
cancer-but t ha t  getting t he  f i r s t  cancer  lowers t he  chances of getting the  second 
cancer ,  because t he  effects  of treatment,  of physiological or behavioral changes, 
or whatever. 
A s  an example, consider again t h e  model in Figure l g ,  but now suppose t ha t  
the  four incidence r a t e s ,  t he  A's, on t he  bottom half of t he  diagram are less than 
the  four A ' s  on the  top  half. Specifically, assume tha t  the  incidence of e i t he r  of 
t he  canoers  among people with t he  o the r  cancer  i s  some fraction of t he  incidence 
among people without t he  o the r  cancer.  Table 4 presents  some values of t he  rela- 
t ive risk of cancer  2 prevalence, R, corresponding to various values of this  f rac-  
tion and various values of the  relative r isk of oancer incidence, t .  The parame- 
ters used resul t  in values of t he  relative risk of canoer  2 prevalence t ha t  are less 
than one. These values, which might be interpreted as indicating tha t  people who 
are more susceptible to t he  f i r s t  cancer  are less susceptible to the  second, were 
produced, however, by a model in which p a r t  of t h e  population is more susceptible 
to both cancers .  
The model of multiple cance r  presented in Figure 1g  is highly simplified. 
Furthermore, t he  evidence concerning multiple cancer  must, as Schoenberg (1977) 
discusses, be  used with g rea t  caution. Nonetheless, t he  model and t h e  evidence are 
perhaps sufficient to draw the  conclusion tha t  the cur ren t  evidence about multiple 
cancer  i s  not inconsistent with the existence of substantial differences among indi- 
Table 4. The value of R ,  the relative risk of cancer 2 prevalence at age 65. for  
various values of r . the relative risk of cancer incidence, A'/ A. the  re- 
lative risk of incidence of a second oancer, and no, the proportion who 
are highly susceptible. 
dour#: Computer oalculations using numerioal methods t o  approximate the model 
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susoeptible group. 
viduals in their  susceptibility to groups of cancers and perhaps even to cancer in 
general. 
Why is Cancer Mortality Jncreauing Over Time? 
As shown in Figure 6, the mortality rate f r o m  canoer among U.S. females aged 
60-64 has remained fairly stable since 1900, whereas total morhlity has fallen to 
close to a third of i ts  1900 level and cardiovascular mortality rates have been cut 
more than 50 percent since 1950. Roughly similar patterns hold at other  ages and 
for  age-standardized rates, f o r  males as well as females, although fo r  males there  
is more of an increase in cancer rates, largely due to lung cancer. Much attention 
has been devoted t o  trying to determine trends in rates of cancer incidence and 
mortality, the causes of such trends, and the implications for  policy (Doll and Peto 
1981, Young and Pollack 1982, Magnus 1982). As explained in this section, hetero- 
geneity makes such efforts are even more difficult than praviously recognized. 
Before discussing why, i t  is useful to consider two other  pieces of evidence. 
It is apparent from Figure 4 that rapid progress has been made recently against 
causes of death o ther  than cancer. For cancer, on the  other  hand, there  is  evi- 
dence of progress at younger ages and evidence of higher death rates at older 
ages. 
If, instead of following a single country o v e r  time, a variety of countries are 
compared at some point in time, a pat te rn  emerges t ha t  may be similar in origin t o  
t he  increasing relat ive importance of cancer  o v e r  time: t he  countries with t he  
highest death rates from o the r  causes tend t o  have the  lowest death rates from 
cancer .  For instance, using age-adjusted death rates f o r  1975 fo r  50 countries 
with widely varying rates (Segi et al. 1981, Appendix Table I), t h e  Spearman corre- 
lation coefficient between the  rate fo r  malignant neoplasms and t h e  rate f o r  all  
o the r  causes of death is -0.27 f o r  males and -0.39 for females. A s  in t he  case of 
temporal t rends,  i t  looks from this kind of cross-sectional da t a  as if progress  
against o t h e r  causes of death is  associated with an  increase in cance r  mortality 
rates. 
Hence, i t  may prove  t o  be  significant tha t  observed cancer  mortality rates fo r  
a population may decrease  slowly, stay roughly level, or even increase even 
though t h e  r i sks  of cancer  f o r  t he  individuals t ha t  comprise t h e  population are de- 
creasing. There are t h r e e  main mechanisms in heterogeneous populations that can 
produce such results.  
(i)  The Eflect of Convergence a n d  Crossover 
A reduction in cancer  mortality at all ages  will, in a heterogeneous popula- 
tion, produce a mortality t ra jec tory  tha t  converges toward and may cross the  pre-  
vious mortality trajectory. A s  a resul t ,  the  observed death rate f r o m  cancer  will 
decline, at all ages  and especially a t  advanced ages,  by less than t h e  correspond- 
ing rate f o r  individuals. A t  ages a f t e r  t he  crossover,  t h e  reduction in the  indivi- 
dual rates p actually resul ts  in an  increase in t he  observed rates j i .  
Table 5 shows the  t rend  in cancer  mortality rates at various ages  at the  indi- 
vidual and population level based on the  prototypical susceptibility model. 
Although among susceptible individuals aance r  mortality rates are declining by 1 
percent  p e r  yea r  at all ages,  the  observed rate at age  70 is declining by less than 
half a percent  p e r  yea r  and the  observed rate at age 80 is  increas ing  by more 
than half a percent  p e r  year .  
( i i )  The m c t  of Compensating Cancers 
Progress  against one form of cancer  may b e  offset by an observed r i s e  in oth- 
er forms fo r  which susceptible individuals face higher risks.  A s  illustrated above 
in Table 2, even if progress  is being made against all  forms of cancer ,  if t h e  rates 
Table 5. Annual rates of progress in reducing cancer death rates a t  various 
ages, for the  susceptible subpopulation and the  entire population. 
Annual rate of progress in reducing cancer death rate: 
Actual rate 
f o r  susceptible Observed rate for  
Age subpopulation entire population 
50 1% 0.96% 
60 1 0.83 
70 1 0.44 
80 1 -0.61 
Source Computer aaloulations using prototyplaal susaeptibility model, desoribed in 
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of progress differ for  different forms of cancer, i t  may appear as if certain canc- 
ers are growing in importance. The observed death ra te ,  at any age and especially 
at older ages, from all f o r m s  of cancer will, as a result, decline more slowly than 
the actual death rate among susceptible individuals. 
( i i i )  TRe m e c t  of' P r o g r e s s  Aga ins t  Other C a u s e s  
A similar effect will result if individuals who are susceptible t o  cancer are 
also more susceptible t o  other  forms of death, as in the prototypical frailty model. 
In this model, the  observed age-specific death rates f r o m  cancer and other  causes 
a r e  linked as described by formulas (4) and (5). The formulas imply that  a propor- 
tional decrease in the death rates f r o m  other causes among the frai ler  and more 
robust subcohorts may result in an increase in the observed death rates from 
cancer, even though the death rates from cancer among susceptible individuals 
remain the s a m e .  Indeed, even if the  death rates from cancer among susceptible 
individuals decrease somewhat, the  observed death rates from cancer may in- 
crease. 
The statistics in Table 6 provide an illustration. On the individual level, mor- 
tality rates from cancer are being reduced, at all ages, by a quarter  of a percent 
p e r  year  and mortality rates from other  causes are being reduced by one percent 
p e r  year. The observed rate of progress against cancer, however, is close to zero 
a t  age 60; a t  ages 70 and 80 i t  looks as if there  is  a substantial rate of increase in 
cancer  mortality. Because f ra i l  individuals a r e  also a t  higher r i sk  from o the r  
causes of death, t he  operation of differential selection also resul ts  in an observed 
r a t e  of progress  against o ther  causes of death that  is lower than the  actual rate 
on the  individual level, but t he  effect h e r e  is  minor. 
Table 6. Annual rates of progress  in reducing death rates at various ages f o r  
cancer  and o the r  causes of death, f o r  the  frai l  and robust  subpopula- 
tions and f o r  the  ent i re  population, produced by t h e  prototypical frail ty 
model. 
Annual rate of progress  in reducing death rate from: 
Cancer Other causes 
Actual rate 
f o r  f rai l  
and robust 
Age subpopulations 
50 0.25% 
60 0.25 
70 0.25 
80 0.25 
Observed 
rate f o r  
ent i re  
population 
0.18% 
0.04 
-0.36 
-1.38 
Actual rate Observed 
f o r  f ra i l  rate f o r  
and robust en t i re  
subpopulations population 
1% 0.99% 
1 0.97 
1 0.96 
1 0.98 
Source Computer oalculations using prototypical frailty model, described in text, with 
n(0) = 0.25; b ( z )  = .0001e'~, pc ( z )  = b z 5  with b  ohosen suoh that 
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DISCUSSION 
Individuals differ in the i r  chances of different causes of death: epidemiolo- 
gists spend much of the i r  time trying to uncover the  risk factors  tha t  underlie 
these differences. Yet nearly al l  studies of competing causes of death assume tha t  
all individuals of t h e  s a m e  age in t he  same population group faae  the  same r isks  
and that  these r i sks  are independent of each other.  The f i r s t  assumption is  clearly 
invalid and, as we have illustrated in this ar t ic le ,  the  second assumption i s  invalid 
f o r  heterogeneous populations, except  in some special circumstances. Even if dif- 
fe ren t  causes of death a r e  independent f o r  individuals in some s ta te  (e.g., f o r  f rai l  
individuals), they will not, in general, be  independent fo r  the  population as a 
whole. 
W e  have illustrated t he  potential impact of heterogeneity and dependent com- 
peting r i sks  by using various puzzles and paradoxes of cance r  mortality to 
motivate t he  analysis. Our goal has  been insight and conceptual advance, not e m -  
pirical analysis or statist ical  inference. That work, clearly important, has  been 
s ta r ted  elsewhere (especially by Manton and his colleagues). I t  will undoubtedly 
grow in significance as more and more realist ic models are developed f o r  particu- 
l a r  diseases contexts and as t he  paradigm shift  continues toward recognition of the  
significance of differential selection in epidemiology, demography, actuar ia l  
mathematics, reliability engineering, and o the r  population disciplines. Examples 
of the  application of heterogeneity modeling to  phenomena as diverse  as ferti l i ty,  
divorce, t he  extinction of families of species, equipment failure,  dental  car ies ,  ac- 
cident proneness and t h e  discovery of new petroleum deposits are reviewed in Vau- 
pel and Yashin (1985a and b). 
This pape r  began with a l ist  of eight puzzles and paradoxes of cancer  epi- 
demiology. I ts  findings can  be  summarized using the  same list. The effects  of dif- 
ferent ia l  selection in a population in which individuals vary in t he i r  susceptibility 
to cancer  in general,  or to various forms of cancer ,  or to various causes  of death 
may partially account for: 
- t he  leveling off and decline of cancer incidence and mortality rates with age, 
- the  fact tha t  a g r e a t e r  proportion of deaths are from cancer  around ages 50 
or 60 than at older  ages,  
- the  g r e a t e r  variation among countries in incidence and mortality rates from 
various forms of cancer  than in incidence and mortality rates f r o m  cance r  in 
general,  
- t he  convergence and crossover  of the  age  t ra jec tor ies  of cancer  rates f o r  
t w o  cohorts,  from different time periods, countries,  histological types, etc., 
- the  negative correlat ion among countries in the  mortality rates from cancer  
vs. o t h e r  causes of death,  
- t he  evidence about multiple cancers ,  namely. tha t  people who have one form 
of cancer  face  about t he  same probability of developing a second form of 
cancer  as people without t he  f i r s t  cancer ,  
- the  increase ove r  time in mortality for some forms of cancer  and decrease  f o r  
o t h e r  forms, and 
- t he  tendency for aancer  incidence and mortality rates to somewhat increase,  
whereas mortality rates from almost all o the r  major causes of death,  including 
hea r t  disease and cerebrovascular  disease, are declining. 
In addition, two o the r  findings are worth highlighting. 
First ,  a variety of different heterogeneity models can produce qualitatively 
similar mortality pat terns  and trajectories.  Simple susceptibility and frail ty 
models t ha t  only distinguish t w o  kinds of individuals were sufficient to i l lustrate 
t h e  points made in this paper .  I t  seems likely, though, t ha t  more elaborate  models 
will f i t  empirical data  be t t e r  than such simple models. Even if some heterogeneity 
model, e.g. t he  prototypical susceptibility model, can be  ruled out because of evi- 
dence, say, tha t  few if any individuals are completely immune to cancer ,  o ther ,  
more elaborate  models may still be  plausible. Indeed, individuals differ  from each 
o the r  along so many important r isk fac tors  tha t  i t  seems incontrovertible tha t  po- 
pulations are heterogeneous: t h e  question is  when does this heterogeneity have an 
important effect  on epidemiological statist ics and, when it  does, how should t h e  
heterogeneity be  modeled? 
Second, even substantial differences among individuals in t h e i r  susceptibility 
to cancer  or to some form of cancer  may not produce a noticeable impact on the  
observed age  t ra jec tory  of cancer  mortality in a population. The impact of such 
differences, however, may significantly alter pat terns  of cance r  mortality ove r  
time or place. Therefore,  t he  absence of strong heterogeneity effects in s o m e  set 
of cancer  statist ics should not be  assumed to exclude strong effects  in o t h e r  sets 
of cancer  statistics. 
These various findings open up new hypotheses and new re sea rch  directions. 
Even less is known about cancer  epidemiology than was previously thought, but 
more can be  learned by systematically considering t h e  effects of differential 
selection in heterogeneous populations. Some key facts  that  were assumed self- 
evident-such as t h e  belief tha t  little or no progress  i s  being made in reducing 
rates of overall  cancer  mortality-may still be  co r r ec t ,  but tha t  remains to b e  es- 
tablished. 
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Susceptible l mmune 
Pcod P,(x) 
Figure l a .  The Prototypical Susceptibility Model. 
Frail Robust 
Figure l b .  The Prototypical Frailty Model. 
More Susceptible Less Susceptible 
r > 
Pc0d Pood P; (XI < Pcod Po (XI = pO(x) < 
Figure lc. A More General Model. 
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Susceptible Immune 
P;(x) $(x)  Po0d Pood 
Figure Id. The Two-Cancer Transition Model. 
More 
Susceptible 
Less 
Susceptible 
Pc(x) Pood P i  ( x )  < PC0d Po(x) 
Figure l e .  The Differing Susceptibility Model. 
Susceptible Immune 
P;Od !$(XI Po()0 
Figure I f .  The Multiple Susceptibility Model. 
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Figure  2a. The o b s e r v e d  f o r c e  of mor ta l i ty  f rom 
c a n c e r  f rom a g e  20 t o  85 produced  by  
t h e  p ro to typ ica l  suscept ib i l i ty  model 
f o r  5 p a i r s  of p a r a m e t e r  va lues .  S e e  
t e x t  f o r  de ta i l s .  
No mortality -, 
from cancer 2 / 
Low mortality 
from cancer 2 
High mortality 
from cancer 2 
F l g u r e  Zb. The o b s e r v o d  f o r c e  of mor t a l l t y  f rom c a n c o r  1 f rom a g e  
20 to 85 p r o d u c e d  by t h e  t w o - c a n c e r  transition model 
f o r  t h r e e  l eve l s  of mor t a l l t y  f rom c a n c o r  2 .  See t e x t  
f o r  d e t a i l s  of t h e  model. The  following p a r a m e t e r s  w a r e  
used:  = 0.01,  p C l ( x )  = bx5 wl th  b  c h o s e n  s u c h  t h a t  
7 5  
J p c l ( x ) d z  = 0.01,  p C 2 ( x )  = bx5 wlth b  c h o s e n  s u c h  
0 
t h a t  J C L , , ( X ) ~ X  = 0, 0.5 ,  a n d  0.9, r n s p e c t i v o l y ,  f o r  
0 
t h e  t h r e e  c u r v e s ,  a n d  k ( x )  = 0 . 0 0 0 1 e ' ~ ~ .  
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age-specific 
incidence 
rates 
(log scale) 
Age-specif ic 
incidence rates 
per 100,000 
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Figure 3a. Age-specific incidence rates from ce rv-  
ical c a n c e r  for cohor t s  of Icelandic 
women born in 1913,  1923, and 1933. 
Adopted: Hakarna (1982). 
Figure 3b.  Age-specific incidence rates f r o m  a g e  
20 to 85 produced by t h e  prototypical  
susceptibility model for t h r e e  sets of 
paramete r  values. S e e  t e x t  for deta i ls  
of model. For  t h e  t h r e e  c ~ l r v e s  f r o m  
l e f t  to r igh t  no i s  0.012, 0.02, and 0.022 
and p ( z )  = a x 6 ,  where  a i s  chosen such 
t 
t h a t  J p ( z ) d z  = 1. 0.99. and 0.9 for t 
0 
= 65, 70, and 75,  respect ively .  






